MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, RGBP made $59,065 in revenue. -$967,853 in net income. Net profit margin of -1638.62%.

Income Overview

Revenue
$59,065
Net Income
-$967,853
Net Profit Margin
-1638.62%
EPS
-$0.01
Unit: Dollar
Revenue Breakdown
    • Nonrelated Party
    • Related Party

Income Statement
2025-12-31
2025-09-30
2025-06-30
2025-03-31
Net revenue
59,065 59,366* 59,065 59,065
Research and development
210,000 11,725* 0 -
General and administrative
231,925 9,045.5* 30,697 13,348
Consulting and professional fees
153,764 123,478* 46,624 136,566
Rent
15,000 22,500* 22,500 22,500
Total operating expenses
610,689 166,748.5* 99,821 172,414
Loss from operations
-551,624 -107,382.5* -40,756 -113,349
Interest expense
26,553 87,835.5* 24,638 22,329
Interest expense attributable to amortization of discount
8,850 14,231* 12,639 12,639
Derivative income (expense)
-380,826 -772,584* -89,259 128,963
Penalties
0 12,500* --
Financing fees
0 ---
Total other income (expense), net
-416,229 -887,150.5* -126,536 93,995
Net loss before income taxes
-967,853 -994,533* -167,292 -19,354
Income tax provision
0 0* 0 -
Net loss
-967,853 -994,533 -167,292 -19,354
Basic EPS
-0.01 -0.039 -0.01 0
Diluted EPS
-0.01 -0.039 -0.01 0
Basic Average Shares
99,609,650 25,258,700 23,752,506 21,554,704
Diluted Average Shares
99,609,650 25,258,700 23,752,506 21,554,704
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$967,853 Net loss beforeincome taxes-$967,853 Nonrelated Party$31,640 Related Party$27,425 Loss from operations-$551,624 Total other income(expense), net-$416,229 Net revenue$59,065 Total operatingexpenses$610,689 Derivative income(expense)-$380,826 Interest expense$26,553 Interest expenseattributable to amortization...$8,850 General andadministrative$231,925 Research and development$210,000 Consulting andprofessional fees$153,764 Rent$15,000

Regen BioPharma Inc (RGBP)

Regen BioPharma Inc (RGBP)